Tyra Biosciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TYRA and other ETFs, options, and stocks.About TYRA
Tyra Biosciences, Inc. is a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer. Its proprietary in-house discovery platform, SNÅP, enables the rapid and precise refinement of structural design through iterative molecular SNÅPshots that help predict genetic alterations most likely to cause acquired resistance to existing therapies.
CEOTodd J. Harris
CEOTodd J. Harris
Employees87
Employees87
HeadquartersCarlsbad, California
HeadquartersCarlsbad, California
Founded2018
Founded2018
Employees87
Employees87
TYRA Key Statistics
Market cap1.97B
Market cap1.97B
Price-Earnings ratio-18.23
Price-Earnings ratio-18.23
Dividend yield—
Dividend yield—
Average volume1.22M
Average volume1.22M
High today$37.00
High today$37.00
Low today$33.61
Low today$33.61
Open price$34.23
Open price$34.23
Volume1.27M
Volume1.27M
52 Week high$40.65
52 Week high$40.65
52 Week low$7.80
52 Week low$7.80
Stock Snapshot
The current Tyra Biosciences(TYRA) stock price is $37.00, with a market capitalization of 1.97B. The stock trades at a price-to-earnings (P/E) ratio of -18.23.
During the trading session on 2026-04-22, Tyra Biosciences(TYRA) shares reached a daily high of $37.00 and a low of $33.61. At a current price of $37.00, the stock is +10.1% higher than the low and still 0.0% under the high.
Trading volume for Tyra Biosciences(TYRA) stock has reached 1.27M, versus its average volume of 1.22M.
The stock's 52-week range extends from a low of $7.80 to a high of $40.65.
The stock's 52-week range extends from a low of $7.80 to a high of $40.65.
Analyst ratings
100%
of 13 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own TYRA. This list is generated using Robinhood data, and it’s not a recommendation.